These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26483758)

  • 1. New drug target in protozoan parasites: the role of thioredoxin reductase.
    Andrade RM; Reed SL
    Front Microbiol; 2015; 6():975. PubMed ID: 26483758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target.
    Debnath A; Parsonage D; Andrade RM; He C; Cobo ER; Hirata K; Chen S; García-Rivera G; Orozco E; Martínez MB; Gunatilleke SS; Barrios AM; Arkin MR; Poole LB; McKerrow JH; Reed SL
    Nat Med; 2012 Jun; 18(6):956-60. PubMed ID: 22610278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprofiled drug targets ancient protozoans: drug discovery for parasitic diarrheal diseases.
    Debnath A; Ndao M; Reed SL
    Gut Microbes; 2013; 4(1):66-71. PubMed ID: 23137963
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Shaulov Y; Sarid L; Trebicz-Geffen M; Ankri S
    Antioxidants (Basel); 2021 Aug; 10(8):. PubMed ID: 34439488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of oxidised (OX) proteins in Entamoeba histolytica exposed to auranofin and consequences on the parasite virulence.
    Shaulov Y; Nagaraja S; Sarid L; Trebicz-Geffen M; Ankri S
    Cell Microbiol; 2020 Jun; 22(6):e13174. PubMed ID: 32017328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I Clinical Trial Results of Auranofin, a Novel Antiparasitic Agent.
    Capparelli EV; Bricker-Ford R; Rogers MJ; McKerrow JH; Reed SL
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target identification and intervention strategies against amebiasis.
    Nagaraja S; Ankri S
    Drug Resist Updat; 2019 May; 44():1-14. PubMed ID: 31112766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Throughput Screening of
    Ehrenkaufer GM; Suresh S; Solow-Cordero D; Singh U
    Front Cell Infect Microbiol; 2018; 8():276. PubMed ID: 30175074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitroimidazole action in Entamoeba histolytica: a central role for thioredoxin reductase.
    Leitsch D; Kolarich D; Wilson IB; Altmann F; Duchêne M
    PLoS Biol; 2007 Aug; 5(8):e211. PubMed ID: 17676992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activity of esters of quinoxaline-7-carboxylate 1,4-di-N-oxide against E. histolytica and their analysis as potential thioredoxin reductase inhibitors.
    Soto-Sánchez J; Caro-Gómez LA; Paz-González AD; Marchat LA; Rivera G; Moo-Puc R; Arias DG; Ramírez-Moreno E
    Parasitol Res; 2020 Feb; 119(2):695-711. PubMed ID: 31907668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug susceptibility testing in microaerophilic parasites: Cysteine strongly affects the effectivities of metronidazole and auranofin, a novel and promising antimicrobial.
    Leitsch D
    Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):321-327. PubMed ID: 28910741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactivity of Farnesyltransferase Inhibitors Against
    Probst A; Nguyen TN; El-Sakkary N; Skinner D; Suzuki BM; Buckner FS; Gelb MH; Caffrey CR; Debnath A
    Front Cell Infect Microbiol; 2019; 9():180. PubMed ID: 31192168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auranofin Resistance in
    Ma CI; Tirtorahardjo JA; Jan S; Schweizer SS; Rosario SAC; Du Y; Zhang JJ; Morrissette NS; Andrade RM
    Front Cell Infect Microbiol; 2021; 11():618994. PubMed ID: 33816332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Potential Anticancer Activity of Auranofin].
    Momose I; Onodera T; Kawada M
    Yakugaku Zasshi; 2021; 141(3):315-321. PubMed ID: 33642497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Entamoeba thiol-based redox metabolism: A potential target for drug development.
    Jeelani G; Nozaki T
    Mol Biochem Parasitol; 2016; 206(1-2):39-45. PubMed ID: 26775086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auranofin inactivates Trichomonas vaginalis thioredoxin reductase and is effective against trichomonads in vitro and in vivo.
    Hopper M; Yun JF; Zhou B; Le C; Kehoe K; Le R; Hill R; Jongeward G; Debnath A; Zhang L; Miyamoto Y; Eckmann L; Land KM; Wrischnik LA
    Int J Antimicrob Agents; 2016 Dec; 48(6):690-694. PubMed ID: 27839893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing Auranofin and Evaluation of a New Gold(I) Compound for the Search of Treatment of Human and Cattle Parasitic Diseases: From Protozoa to Helminth Infections.
    Feng L; Pomel S; Latre de Late P; Taravaud A; Loiseau PM; Maes L; Cho-Ngwa F; Bulman CA; Fischer C; Sakanari JA; Ziniel PD; Williams DL; Davioud-Charvet E
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33139647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting Drug Development Against the Neglected Tropical Disease, Amebiasis.
    Shrivastav MT; Malik Z; Somlata
    Front Cell Infect Microbiol; 2020; 10():628257. PubMed ID: 33718258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sensibility of Entamoeba histolytica trophozoites to ivermectin].
    González-Salazar F; Mata-Cárdenas BD; Vargas-Villareal J
    Medicina (B Aires); 2009; 69(3):318-20. PubMed ID: 19622479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavonoids as a Natural Treatment Against
    Martínez-Castillo M; Pacheco-Yepez J; Flores-Huerta N; Guzmán-Téllez P; Jarillo-Luna RA; Cárdenas-Jaramillo LM; Campos-Rodríguez R; Shibayama M
    Front Cell Infect Microbiol; 2018; 8():209. PubMed ID: 29988403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.